Headlinne
Sign inGet Headlinne
Medical Xpress·4 min read·hard

New strategy could prevent T cell exhaustion and boost immunotherapy

J
Jim Stallard
New strategy could prevent T cell exhaustion and boost immunotherapy
✦AI Summary

Researchers at Memorial Sloan Kettering Cancer Center have identified that the signaling molecule MEK contributes to T cell exhaustion in cancer patients. Blocking MEK could potentially extend the effectiveness of immunotherapy treatments.

Why it mattersUnlock →

by Jim Stallard, Memorial Sloan Kettering Cancer Center

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscience
Political bias analysisUnlock →
Read originalGet full access
✦

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in

New strategy could prevent T cell exhaustion and boost immunotherapy — Headlinne — headlinne